Last reviewed · How we verify

NCT07449663: HIIT-KICK

SPORT-SPECIFIC HIIT IN ELITE KICKBOXERS

Active, enrolled NA Last updated 4 March 2026
What this trial tests

NA trial testing Sport-Specific High-Intensity Interval Training in Exercise Training Adaptation in 40 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
15 January 2026
Primary endpoint
15 March 2026
15 March 2026

Quick facts

Lead sponsorAdiyaman University
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposebasic science
Enrollment40
Start date15 January 2026
Primary completion15 March 2026
Estimated completion15 March 2026
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Adiyaman University

Who can join

Adults 18 to 30, male only, with Exercise Training Adaptation or Exercise Physiology. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study examines how sport-specific high-intensity interval training (HIIT) affects the body in elite kickboxers. Participants are randomly assigned to either a HIIT training group or a control group. The HIIT group performs supervised sport-specific training for eight weeks, while the control group continues their usual training. Blood samples are collected before and after the training period. The main goal of this study is to determine whether HIIT changes levels of exercise-related proteins such as apelin and irisin. These proteins may reflect how the body adapts to intense training. The findings may help researchers and coaches better understand the effects of high-intensity training and may support the development of safer and more effective training programs for athletes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Adiyaman University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07449663.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing